Standout Papers

Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo 1991 2026 2002 2014 2.1k
  1. Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo (1991)
    Debra S. Echt, Philip R. Liebson et al. New England Journal of Medicine

Immediate Impact

8 from Science/Nature 77 standout
Sub-graph 1 of 15

Citing Papers

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy
2020 Standout
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary
2020 Standout
63 intermediate papers

Works of Daniel Arensberg being referenced

Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo
1991 Standout
Once‐daily pravastatin in patients with primary hypercholesterolemia: A dose‐response study
1991

Author Peers

Author Last Decade Papers Cites
Daniel Arensberg 1749 198 101 349 12 2.3k
Allan H. Barker 2140 153 68 373 13 2.6k
Dulce Obias-Manno 1674 114 57 343 5 2.1k
Anne B. Cropp 2256 454 186 173 13 2.7k
Tina Ken Schramm 1472 507 181 263 24 2.7k
Bridget‐Anne Kirwan 1861 369 174 192 44 3.4k
Rebecca A. Boyd 1332 253 134 167 34 2.3k
Richard Rohde 2810 335 155 389 8 4.6k
M. Schultz 1979 414 66 191 12 2.6k
K L Woods 1017 234 111 241 54 2.0k
Gordon H. Williams 2008 345 104 369 41 3.2k

All Works

Loading papers...

Rankless by CCL
2026